SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2024 • MAIA Biotechnology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 11, 2024, between MAIA Biotechnology, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).